Related Experiment Videos
Prevalence of anticardiolipin antibodies in various thrombotic conditions: a hospital-based study
S Chandrashekhara1, R Kirthi, Joyce Varghese
1Department of Immunology, MS Ramaiah Medical College, Bangalore.
Insights
Anticardiolipin antibodies (aCL) are a common acquired thrombophilic defect. This study found aCL IgG in 20.77% of patients, with deep vein thrombosis being the most frequent manifestation.
Area of Science:
- Hematology
- Immunology
- Vascular Medicine
Background:
- Thrombosis is a leading global cause of mortality.
- Anticardiolipin antibodies (aCL) are recognized as a frequent acquired protein defect contributing to thrombosis.
- Understanding the incidence of aCL in diverse thrombotic conditions is crucial.
Purpose of the Study:
- To determine the incidence of anticardiolipin antibodies (aCL) in patients presenting with various thrombotic events.
- To investigate the association between aCL IgG and specific thrombotic conditions.
Main Methods:
- Retrospective screening of 302 patients for aCL IgG using enzyme-linked immunosorbent assay (ELISA).
- Collection of detailed clinical and epidemiological data from patient records and examinations.
Main Results:
- High titers of aCL IgG were detected in 65 (20.77%) of the 302 patients.
- Deep vein thrombosis (DVT) was the most common thrombotic event (29.8%), with aCL IgG incidence of 13.79%.
- aCL IgG was also observed in coronary artery (25.0%), central nervous system arteries (17.21%), and peripheral arteries (18.75%) thrombosis.
Conclusions:
- Anticardiolipin antibodies (aCL) represent the most prevalent acquired thrombophilic defect.
- Further epidemiological data specific to the population studied is necessary to refine strategies for thrombosis research in aCL-positive individuals.
Unlabelled:
Thrombosis is one of the leading cause of death, globally, anticardiolipin antibodies (aCL) has been implicated as one of the most common acquired protein defect causing thrombosis. This study was undertaken to evince the incidence of aCL in various thrombotic settings.
Material And Methods:
Three hundred and two patients were retrospectively screened for the incidence of aCL The sera were screened for aCL IgG using enzyme linked immunosorbent assay. Detail clinical and epidemiological data were obtained from hospital records and clinical examination.
Results:
Among the 302 patients, 134 (44.37%) were below the age of 40 years (juvenile-onset thrombosis), mean age being 35.3 years. High titres of aCL IgG was seen in 65 (20.77%) patients. Deep vein thrombosis (DVT), seen in 90 (29.8%) was the most common thrombotic condition. Other sites of thrombosis were coronary artery (19.2%), central nervous system territory arteries (17.21%) and peripheral arteries (5.29%); the incidence of aCL IgG in these sites were 13.79%, 25.0% and 18.75% respectively.
Conclusion:
aCL is the most common acquired thrombophilic defect. Epidemiological data of our population is required for evaluating the strategy for further research of thrombosis in this condition.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care